Emily Celeste Law, APN
Family · Newark
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Emily Celeste Law’s office at (888) 731-8994 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$115,979
Medicare paid this office $115,979 for 219 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 31 | $38,563 | None |
| Return visit (30+ min) | 143 | $19,032 | $89 |
| Long return visit (40+ min) | 55 | $10,829 | $127 |
| New patient visit (45+ min) | 95 | $10,289 | $108 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $3,092 | $52 |
See all 8 services
| Injection, denosumab, 1 mg | 31 | $38,563 | None |
| Return visit (30+ min) | 143 | $19,032 | $89 |
| Long return visit (40+ min) | 55 | $10,829 | $127 |
| New patient visit (45+ min) | 95 | $10,289 | $108 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $3,092 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 108 | $1,935 | $11 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,158 | $58 |
| Injection, methylprednisolone acetate, 1 mg | 21 | $255 | None |
Procedures year by year
| Procedure | 2021 | 2024 |
|---|---|---|
| Aspiration and/or injection of fluid from large joint | – | 20 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
219 Original Medicare patients in 2024. Average age 72 · Under 65 11% · 85 and older 8% · Women 79% · Also on Medicaid 14% · Health risk score 1.19. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 71% · Diabetes 30% · Coronary heart disease 24% · Chronic kidney disease 23% · COPD 22% · Depression 18% · Atrial fibrillation 12% · Heart failure 11% · Cancer 11% · Stroke 11%.
The office billed $585,388, Medicare allowed $146,857 and paid $115,979; for 10,641 services of 22 kinds; $67,566 of it was for drugs given in the office and $48,413 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 219 | 10,641 | 72 | 1.19 | $585,388 | $115,979 |
| 2021 | 16 | 69 | 73 | 1.45 | $8,718 | $2,579 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Short return visit (20+ min) | 12 | $828 | $64 |
Medicaid work
$5,117 in 2024
Medicaid paid $5,117 for 48 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 48 | $5,117 |
| 2024 | 48 | 1 | 18 | $5,117 |
Drugs they prescribed that Part D paid
$170,372
Pharmacies billed $170,372 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (134 of 1,208) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,154 generic and fewer than 11 brand-name prescriptions · $170,372 in drug cost · 19 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Actemra | 14 | $16,745 | $1,196 |
| Hydroxychloroquine Sulfate | 132 | $6,003 | $45 |
| Leflunomide | 35 | $2,700 | $77 |
| Methotrexate | 116 | $2,548 | $22 |
| Febuxostat | 16 | $2,079 | $130 |
See all 21 drugs
| Actemra | 14 | $16,745 | $1,196 |
| Hydroxychloroquine Sulfate | 132 | $6,003 | $45 |
| Leflunomide | 35 | $2,700 | $77 |
| Methotrexate | 116 | $2,548 | $22 |
| Febuxostat | 16 | $2,079 | $130 |
| Pregabalin | 73 | $1,282 | $18 |
| Colchicine | 22 | $1,041 | $47 |
| Prednisone | 127 | $1,019 | $8 |
| Pilocarpine | 15 | $859 | $57 |
| Gabapentin | 60 | $680 | $11 |
| Duloxetine | 21 | $467 | $22 |
| Azathioprine | 15 | $439 | $29 |
| Methylprednisolone | 59 | $404 | $7 |
| Tramadol | 107 | $393 | $4 |
| Alendronate | 29 | $337 | $12 |
| Meloxicam | 65 | $274 | $4 |
| Folic Acid | 17 | $257 | $15 |
| Hydrocodone-Acetaminophen | 13 | $249 | $19 |
| Cyclobenzaprine | 27 | $192 | $7 |
| Allopurinol | 13 | $138 | $11 |
| Naproxen | 14 | $132 | $9 |
Year by year
| 2024 | 1,208 | 377 | 11% (134) | None | $170,372 |
| 2023 | 1,253 | 206 | 6% (72) | None | $451,740 |
| 2022 | 1,339 | 214 | 6% (81) | None | $266,043 |
| 2021 | 1,313 | 220 | 5% (60) | None | $544,935 |
| 2020 | 1,468 | 224 | 5% (76) | None | $528,266 |
| 2019 | 739 | 169 | 4% (31) | None | $451,041 |
| 2018 | 208 | 40 | 12% (25) | 19% | $119,619 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Enbrel Sureclick | 18 | $188,679 | $10,482 |
| Kevzara | 14 | $57,052 | $4,075 |
| Methotrexate | 230 | $8,592 | $37 |
| Hydroxychloroquine Sulfate | 129 | $7,722 | $60 |
| Savella | 12 | $5,625 | $469 |
| Leflunomide | 98 | $4,958 | $51 |
| Colchicine | 24 | $2,168 | $90 |
| Prednisone | 142 | $1,365 | $10 |
| Celecoxib | 12 | $998 | $83 |
| Azathioprine | 34 | $923 | $27 |
| Amitriptyline | 25 | $846 | $34 |
| Gabapentin | 66 | $818 | $12 |
| Diclofenac | 20 | $812 | $41 |
| Trazodone | 14 | $657 | $47 |
| Ibandronate | 15 | $487 | $32 |
| Tramadol | 50 | $341 | $7 |
| Allopurinol | 16 | $299 | $19 |
| Duloxetine | 14 | $297 | $21 |
| Alendronate | 14 | $222 | $16 |
| Meloxicam | 44 | $214 | $5 |
| Sulfasalazine | 11 | $155 | $14 |
| Hydrocodone-Acetaminophen | 12 | $143 | $12 |
| Venlafaxine | 12 | $80 | $7 |
| Lisinopril | 13 | $73 | $6 |
| Folic Acid | 17 | $54 | $3 |
2022: 24 drugs
| Kevzara | 13 | $50,632 | $3,895 |
| Hydroxychloroquine Sulfate | 184 | $12,331 | $67 |
| Methotrexate | 227 | $8,359 | $37 |
| Leflunomide | 76 | $8,169 | $107 |
| Colchicine | 36 | $5,465 | $152 |
| Savella | 11 | $5,181 | $471 |
| Gabapentin | 72 | $1,471 | $20 |
| Azathioprine | 39 | $1,365 | $35 |
| Prednisone | 183 | $1,256 | $7 |
| Hydrocodone-Acetaminophen | 24 | $1,218 | $51 |
| Febuxostat | 13 | $1,174 | $90 |
| Amitriptyline | 32 | $983 | $31 |
| Celecoxib | 24 | $696 | $29 |
| Diclofenac | 26 | $662 | $25 |
| Duloxetine | 12 | $652 | $54 |
| Pregabalin | 17 | $472 | $28 |
| Sulfasalazine | 16 | $252 | $16 |
| Tramadol | 52 | $251 | $5 |
| Allopurinol | 24 | $204 | $9 |
| Meloxicam | 43 | $159 | $4 |
| Folic Acid | 25 | $148 | $6 |
| Zolpidem | 11 | $104 | $9 |
| Omeprazole | 12 | $98 | $8 |
| Alprazolam | 14 | $33 | $2 |
2021: 27 drugs
| Enbrel Sureclick | 22 | $155,598 | $7,073 |
| Rinvoq | 17 | $91,428 | $5,378 |
| Kevzara | 12 | $45,491 | $3,791 |
| Hydroxychloroquine Sulfate | 226 | $15,637 | $69 |
| Methotrexate | 219 | $7,905 | $36 |
| Savella | 15 | $7,479 | $499 |
| Leflunomide | 62 | $6,429 | $104 |
| Febuxostat | 27 | $5,459 | $202 |
| Colchicine | 36 | $4,457 | $124 |
| Celecoxib | 15 | $1,464 | $98 |
| Gabapentin | 64 | $1,224 | $19 |
| Prednisone | 107 | $956 | $9 |
| Pregabalin | 18 | $929 | $52 |
| Sulfasalazine | 32 | $841 | $26 |
| Azathioprine | 19 | $600 | $32 |
| Amitriptyline | 17 | $519 | $31 |
| Hydrocodone-Acetaminophen | 13 | $475 | $37 |
| Duloxetine | 20 | $383 | $19 |
| Allopurinol | 33 | $345 | $10 |
| Diclofenac | 16 | $318 | $20 |
| Meloxicam | 49 | $265 | $5 |
| Tramadol | 43 | $222 | $5 |
| Omeprazole | 15 | $145 | $10 |
| Ibuprofen | 14 | $144 | $10 |
| Alendronate | 16 | $137 | $9 |
| Folic Acid | 22 | $104 | $5 |
| Trazodone | 11 | $101 | $9 |
2020: 23 drugs
| Enbrel Sureclick | 29 | $173,088 | $5,969 |
| Hydroxychloroquine Sulfate | 204 | $23,824 | $117 |
| Methotrexate | 285 | $12,133 | $43 |
| Febuxostat | 34 | $8,445 | $248 |
| Leflunomide | 76 | $8,027 | $106 |
| Savella | 13 | $6,207 | $477 |
| Colchicine | 19 | $4,629 | $244 |
| Celecoxib | 21 | $1,367 | $65 |
| Duloxetine | 24 | $1,318 | $55 |
| Azathioprine | 26 | $1,313 | $51 |
| Prednisone | 134 | $1,084 | $8 |
| Diclofenac | 47 | $969 | $21 |
| Hydrocodone-Acetaminophen | 24 | $891 | $37 |
| Sulfasalazine | 36 | $862 | $24 |
| Gabapentin | 55 | $756 | $14 |
| Allopurinol | 33 | $366 | $11 |
| Amitriptyline | 26 | $363 | $14 |
| Trazodone | 14 | $350 | $25 |
| Methotrexate | 21 | $293 | $14 |
| Tramadol | 42 | $274 | $7 |
| Meloxicam | 38 | $197 | $5 |
| Nortriptyline | 15 | $146 | $10 |
| Alendronate | 13 | $90 | $7 |
2019: 19 drugs
| Serostim | 12 | $173,615 | $14,468 |
| Triumeq | 16 | $45,159 | $2,822 |
| Truvada | 22 | $40,356 | $1,834 |
| Hydroxychloroquine Sulfate | 60 | $5,785 | $96 |
| Methotrexate | 83 | $2,732 | $33 |
| Leflunomide | 15 | $2,638 | $176 |
| Dextroamphetamine-Amphetamine | 26 | $903 | $35 |
| Azathioprine | 11 | $512 | $47 |
| Tamsulosin | 12 | $364 | $30 |
| Gabapentin | 14 | $307 | $22 |
| Prednisone | 38 | $240 | $6 |
| Allopurinol | 14 | $235 | $17 |
| Finasteride | 11 | $122 | $11 |
| Clotrimazole | 11 | $108 | $10 |
| Tramadol | 11 | $107 | $10 |
| Lisinopril | 19 | $98 | $5 |
| Amlodipine Besylate | 11 | $61 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $49 | $4 |
| Metoprolol | 13 | $21 | $2 |
2018: 3 drugs
| Dextroamphetamine-Amphetamine | 26 | $812 | $31 |
| Hydrocodone-Acetaminophen | 12 | $168 | $14 |
| Zolpidem | 14 | $103 | $7 |
Money from drug and device companies
$223 in 2025
| 2025 | 1 | 20 | None | $223 |
| 2024 | 16 | 62 | None | $1,109 |
| 2023 | 16 | 126 | None | $2,658 |
| 2022 | 16 | 196 | None | $3,634 |
| 2021 | 9 | 87 | None | $1,641 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Cosentyx | $223 | 20 payments
|
See all 20 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-08 | Cosentyx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-11-17 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-10-20 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-10-02 | Cosentyx | $3 |
| Novartis Pharmaceuticals | Meals · 2025-09-22 | Cosentyx | $9 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Cosentyx | $11 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Cosentyx | $11 |
| Novartis Pharmaceuticals | Meals · 2025-08-29 | Cosentyx | $12 |
| Novartis Pharmaceuticals | Meals · 2025-08-29 | Cosentyx | $12 |
| Novartis Pharmaceuticals | Meals · 2025-08-18 | Cosentyx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-08-18 | Cosentyx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-07-29 | Cosentyx | $10 |
| Novartis Pharmaceuticals | Meals · 2025-07-21 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-06-30 | Cosentyx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-06-23 | Cosentyx | $9 |
| Novartis Pharmaceuticals | Meals · 2025-06-04 | Cosentyx | $3 |
| Novartis Pharmaceuticals | Meals · 2025-05-27 | Cosentyx | $5 |
| Novartis Pharmaceuticals | Meals · 2025-05-05 | Cosentyx | $17 |
| Novartis Pharmaceuticals | Meals · 2025-04-18 | Cosentyx | $6 |
| Novartis Pharmaceuticals | Meals · 2025-03-03 | Cosentyx | $13 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,109
| Abbvie | Rinvoq | $253 | 16 payments
|
| Amgen | Evenity | $208 | 12 payments
|
| Janssen Biotech | Tremfya | $199 | 7 payments
|
| Ucb | Cimzia | $84 | 5 payments
|
| Genzyme | Kevzara | $57 | 3 payments
|
| Pfizer | Xeljanz | $52 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $43 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $43 | 3 payments
|
| Scilex Pharmaceuticals | Ztlido | $35 | 2 payments
|
| Lilly USA | Taltz | $29 | 2 payments
|
| Radius Health | None | $23 | 1 payment
|
| Sandoz | Hyrimoz | $22 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $18 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $16 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $14 | 1 payment
|
| GlaxoSmithKline | Benlysta | $14 | 1 payment
|
2023: $2,658
| Abbvie | Skyrizi | $692 | 27 payments
|
| Novartis Pharmaceuticals | Cosentyx | $370 | 27 payments
|
| Amgen | Evenity | $362 | 17 payments
|
| Ucb | Cimzia | $235 | 12 payments
|
| GlaxoSmithKline | Benlysta | $205 | 11 payments
|
| Pfizer | Xeljanz | $167 | 6 payments
|
| Horizon Therapeutics plc | Krystexxa | $113 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $104 | 4 payments
|
| Janssen Biotech | Remicade | $96 | 4 payments
|
| Lilly USA | Taltz | $69 | 3 payments
|
| Octapharma USA | Octagam Immune Globulin (Human) | $69 | 3 payments
|
| Fresenius Kabi USA | Idacio | $60 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $37 | 2 payments
|
| Radius Health | Tymlos | $34 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $24 | 1 payment
|
| Ultragenyx Pharmaceutical | None | $21 | 1 payment
|
2022: $3,634
| Abbvie | Rinvoq | $898 | 42 payments
|
| Amgen | Enbrel | $554 | 22 payments
|
| Novartis Pharmaceuticals | Cosentyx | $428 | 40 payments
|
| Janssen Biotech | Remicade | $385 | 19 payments
|
| Ucb | Cimzia | $374 | 21 payments
|
| Aurinia Pharma U.S. | Lupkynis | $190 | 8 payments
|
| GlaxoSmithKline | Benlysta | $162 | 12 payments
|
| Pfizer | Xeljanz | $141 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $140 | 7 payments
|
| Horizon Therapeutics plc | Krystexxa | $122 | 9 payments
|
| Lilly USA | Taltz | $74 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $60 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $32 | 2 payments
|
| DePuy Synthes Sales | Monovisc | $30 | 1 payment
|
| Radius Health | Tymlos | $23 | 1 payment
|
| Octapharma USA | Octagam Immune Globulin (Human) | $22 | 1 payment
|
2021: $1,641
| AbbVie | Rinvoq | $371 | 19 payments
|
| Novartis Pharmaceuticals | Cosentyx | $366 | 21 payments
|
| Amgen | Enbrel | $291 | 16 payments
|
| GlaxoSmithKline | Benlysta | $230 | 12 payments
|
| Janssen Biotech | Remicade | $145 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $117 | 6 payments
|
| Ucb | Cimzia | $66 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $34 | 2 payments
|
| Genzyme | Kevzara | $21 | 1 payment
|
Professional record
- NPI
- 1124532460
- Licence
- CA NP95006620, NJ 26NJ14929300
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 1 Gateway Ctr Ste 2600, Newark, NJ, 07102
- NPI first listed
- 2017-11-22
- NPI last updated
- 2026-02-20
- NPI record certified
- 2026-02-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306 · 429 4th Ave Fl 7, Pittsburgh, PA, 15219